AMY PATEL: Open Payments
NPI 1528491958 · PLYMOUTH MEETING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$895 in 41 payments from 18 companies in 2025. Trend: 2023 $1,563 · 2024 $1,025 · 2025 $895
Food & beverage: $786Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $197 |
| Verona Pharma, Inc. | 5 | $106 |
| Neurocrine BioSciences, Inc. | 4 | $77 |
| Mannkind Corporation | 3 | $61 |
| Otsuka America Pharmaceutical, Inc. | 4 | $58 |
| Lilly USA, LLC | 2 | $52 |
| UCB, Inc. | 2 | $49 |
| ARGENX US, INC. | 2 | $41 |
| Novo Nordisk Inc | 2 | $40 |
| Amphastar Pharmaceuticals, Inc. | 2 | $40 |
Products named: Ohtuvayre, AUSTEDO XR, INGREZZA, AFREZZA, REXULTI, MOUNJARO, VRAYLAR, Kerendia.
Industry payments across PA — which companies pay providers there.
